PRECISION BIOSCIENCES INC

For the period ended Jun 30, 2025. Filed Aug 7, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 7, 2025

DTIL$9.68-8.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Statements of Operations

(In thousands, except share and per share amounts)

	For the Three Months Ended June 30,		For the Six Months Ended June 30,
	2025	2024	2025	2024
Revenue	$18	$49,898	$47	$67,482
Operating expenses
Research and development	12,768	17,225	26,356	30,568
General and administrative	9,127	8,527	17,680	16,955
Total operating expenses	21,895	25,752	44,036	47,523
Operating (loss) income	(21,877)	24,146	(43,989)	19,959
Other (expense) income:
(Loss) gain from equity method investment	(665)	(950)	677	763
(Loss) gain on changes in fair value	(2,464)	694	(2,415)	346
Gain (loss) on change in fair value of warrant liability	753	7,765	(51)	18,151
Interest expense	(358)	(560)	(712)	(1,134)
Interest income	1,116	1,843	2,439	3,506
Loss on disposal of assets	(25)	(189)	(34)	(254)
Total other (expense) income	(1,643)	8,603	(96)	21,378
(Loss) income from operations	$(23,520)	$32,749	$(44,085)	$41,337
Net (loss) income	$(23,520)	$32,749	$(44,085)	$41,337
Net (loss) income per share
Basic	$(2.13)	$4.70	$(4.33)	$6.87
Diluted	$(2.13)	$4.67	$(4.33)	$6.81
Weighted-average shares of common stock outstanding
Basic	11,046,401	6,966,680	10,174,193	6,013,829
Diluted	11,046,401	7,011,630	10,174,193	6,067,620

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.